Works matching IS 15330028 AND DT 2012 AND VI 11 AND IP 2
Results: 11
To Give or Not to Give Anti–Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies to Patients With KRAS G13D Mutation in Advanced Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2012, v. 11, n. 2, p. 85, doi. 10.1016/j.clcc.2011.10.005
- By:
- Publication type:
- Article
Acute myeloid leukemia secondary to oxaliplatin treatment for esophageal cancer.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild-type metastatic colorectal cancer.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Safety analysis of FOLFOX4 treatment in colorectal cancer patients: a comparison between two Asian studies and four Western studies.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Clinical decision aids in colon cancer: a comparison of two predictive nomograms.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Phase III trial of cetuximab, bevacizumab, and 5-fluorouracil/leucovorin vs. FOLFOX-bevacizumab in colorectal cancer.
- Published in:
- 2012
- By:
- Publication type:
- journal article
A retrospective study of treatment outcomes in patients with carcinoma of unknown primary site and a colorectal cancer molecular profile.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Effectiveness of liver metastasectomies in patients with metastatic colorectal cancer treated with FIr-B/FOx triplet chemotherapy plus bevacizumab.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Preoperative Radiation Therapy for Upper Rectal CancerT3,T4/Nx: Selectivity Essential.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Literature review and practical aspects on the management of oxaliplatin-associated toxicity.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
To give or not to give anti-epidermal growth factor receptor (EGFR) monoclonal antibodies to patients with KRAS G13D mutation in advanced colorectal cancer.
- Published in:
- 2012
- By:
- Publication type:
- Editorial